NLRP3 and metabolic dysfunction-associated steatohepatitis: During the development of NASH disease, saturated fatty acids can induce activation of the NLRP3-ASC inflammasome, activate caspase-1, make IL-1β and mature IL-18, and autophagosomes and mitochondrial active oxygen species are also involved43,44.